http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009508942-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 |
filingDate | 2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2009-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2009508942-A |
titleOfInvention | Oral vehicle for systemic drugs |
abstract | The osmotic drug delivery means includes semi-solid gel boluses, each of which contains the active ingredient and is packaged in blister packs, one at a time or in a cooperating set, or separated into containers. When put in the mouth, the bolus disintegrates and breaks down, releasing the active ingredient. Salivary stimulants, flavoring agents and other additives aid in swallowing. The active ingredient particles may be encapsulated by a hard gel coat. Active ingredients include “over-the-counter” drugs and drugs that require a prescription. Applications include self-treatment in situations where there is no water (especially public transportation), pediatric drugs, seizure patients and elderly drugs. |
priorityDate | 2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 148.